HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Impaired 11-beta hydroxysteroid dehydrogenase type 2 activity in sweat gland ducts in human essential hypertension.

Abstract
The enzyme 11-beta hydroxysteroid dehydrogenase type 2 plays a major role in blood pressure regulation. It metabolizes glucocorticoid hormones into derivatives with low affinity for the mineralocorticoid receptor, preventing its permanent occupancy by circulating cortisol, which is 100- to 1000-fold more abundant than aldosterone in the plasma. Inactivating mutations of the enzyme result in severe hypertension, as seen in children with apparent mineralocorticoid excess syndrome. In patients with essential hypertension, however, attempts to evidence enzyme deficiency have been inconclusive. In this pilot study, its catalytic activity was measured directly in aldosterone-sensitive sweat gland ducts collected from skin biopsy samples of 10 male normotensive subjects and 10 subjects with essential hypertension (more than 140 to 90 mm Hg) with no sign of hypermineralocorticism. Isolated ducts were assayed for nicotinamide-dinucleotide-dependent dehydrogenase activity (transformation of tritiated corticosterone into tritiated-11 dehydrocorticosterone, as measured by high-pressure liquid chromatography). Hypertensive patients exhibited significantly lower 11-beta hydroxysteroid dehydrogenase type 2 activity (9.7+/-4.7 femtomoles per 3 mm length of duct and per 10 minutes incubation, median+/-SD) than did normotensive subjects (15.9+/-2.6). Such defect was undetectable using the classical urinary corticosteroid metabolism indexes, probably because of compensatory mechanisms. Relations between these findings and blood pressure levels should benefit from direct enzyme measurements in the vasculature. In conclusion, this cross-sectional study points to partial 11-beta hydroxysteroid dehydrogenase type 2 deficiency as a novel feature of essential hypertension, which should stimulate search for new signaling pathways and therapeutical targets.
AuthorsBrigitte Bocchi, Sabine Kenouch, Maxime Lamarre-Cliche, Martine Muffat-Joly, Michel Hubert Capron, Jean Fiet, Gilles Morineau, Michel Azizi, Jean Pierre Bonvalet, Nicolette Farman
JournalHypertension (Dallas, Tex. : 1979) (Hypertension) Vol. 43 Issue 4 Pg. 803-8 (Apr 2004) ISSN: 1524-4563 [Electronic] United States
PMID14981055 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Adrenal Cortex Hormones
  • Bicarbonates
  • Blood Glucose
  • Electrolytes
  • NAD
  • Uric Acid
  • Aldosterone
  • Creatinine
  • 11-beta-Hydroxysteroid Dehydrogenase Type 2
  • Renin
  • Corticosterone
Topics
  • 11-beta-Hydroxysteroid Dehydrogenase Type 2 (genetics, metabolism)
  • Adrenal Cortex Hormones (blood, urine)
  • Adult
  • Aldosterone (blood)
  • Bicarbonates (blood)
  • Biopsy
  • Blood Glucose (analysis)
  • Body Mass Index
  • Chromatography, High Pressure Liquid
  • Corticosterone (metabolism)
  • Creatinine (blood)
  • Cross-Sectional Studies
  • Electrolytes (blood, urine)
  • Humans
  • Hypertension (blood, enzymology, genetics, urine)
  • Male
  • Middle Aged
  • NAD (metabolism)
  • Pilot Projects
  • Renin (blood)
  • Sensitivity and Specificity
  • Sweat Glands (enzymology)
  • Uric Acid (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: